|
Wednesday, 05 Dec 2007
Mid-term results from the Athenian Registry revealed at CIRSE 2007 [read more]
|
|
|
|
|
|
Wednesday, 05 Dec 2007
Lencioni presents the first evidence of synergy between RFA and controlled and sustained local delivery of a chemotherapeutic agent, DC Bead [read more]
|
|
|
|
|
|
Wednesday, 05 Dec 2007
In a Phase I-II clinical study, irinotecan was used for hepatic artery infusion in the treatment of unresectable and pre-treated liver metastases from colorectal cancer [read more]
|
|
|
|
|
|
Wednesday, 05 Dec 2007
Results from the PRECISION V randomised clinical study presented at CIRSE [read more]
|
|
|
|
|
|
Wednesday, 05 Dec 2007
Multi-disciplinary speakers discuss the scientific rationale for TACE as well as the health and safety aspects that need to be considered [read more]
|
|
|
|
|
|
|
Wednesday, 05 Dec 2007
Ducreux presents an oncological perspective on the treatment of HCC [read more]
|
|
|
|
|
|
|
Wednesday, 05 Dec 2007
Krämer discusses the mixtures of Lipiodol and cytotoxic drug solutions, and explains why they are not very stable [read more]
|
|
|
|
|
|
|
Wednesday, 05 Dec 2007
Lencioni presents a critical evaluation of device selection and delivery technique, from the perspective of an interventional radiologist [read more]
|
|
|
|
|
|
|
Wednesday, 05 Dec 2007
Dr David J Breen, Southampton University Hospital, UK [read more]
|
|
|
|
|
|
Wednesday, 05 Dec 2007
|
|
|
|
|
